三鑫医疗：2025年营收16.40亿元，净利润同比增15.43%

Core Viewpoint - Sanxin Medical announced a total operating revenue of 1.64 billion yuan for the fiscal year 2025, representing a year-on-year growth of 9.31% [1] Financial Performance - The net profit attributable to shareholders of the listed company reached 262 million yuan, an increase of 15.43% year-on-year [1] - The net profit after deducting non-recurring gains and losses was 239 million yuan, reflecting a year-on-year growth of 14.01% [1] Asset and Equity Growth - As of the end of the reporting period, total assets amounted to 2.427 billion yuan, which is a 9.19% increase compared to the beginning of the period [1] - The equity attributable to shareholders of the listed company was 1.456 billion yuan, showing a growth of 9.95% from the start of the period [1] - The net asset per share stood at 2.79 yuan, marking a 10.28% increase from the beginning of the period [1] Reporting Status - The performance report is unaudited, with specific data to be disclosed in the annual report [1]